Biologics & Biosimilars · Infectious Disease Therapeutics
Invivyd: Products & infrastructure
Invivyd has 9 clinical trials on record, 3 under way.
Data updated Nov 20, 2026 · Back to the company report
Products
Invivyd has 9 clinical trials on record, 3 under way.
9clinical trials
3trials under way
5in phase 3
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 1 more records
Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome
phase 2 · under way · 130 participants · Long COVID; COVID-19 (SARS-CoV-2 Infection); COVID 19 Vaccine; COVID Long
Oct 2026
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With …
phase 3 · completed · 210 participants · COVID-19
Jun 2026
Study of VYD2311 for the Prevention of COVID-19
phase 3 · under way · 1,770 participants · COVID-19
Jan 2026
A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants
phase 1 · under way · 40 participants · COVID-19
Aug 2024
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged …
phase 3 · completed · 790 participants · COVID-19; SARS-CoV-2
Sep 2023
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adul…
phase 1 · completed · 30 participants · COVID-19
Mar 2023
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19
phase 3 · stopped or withdrawn · 399 participants · COVID-19
Jul 2021
Evaluation of ADG20 for the Prevention of COVID-19
phase 3 · stopped or withdrawn · 2,582 participants · COVID-19
Apr 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
